ZA964880B - Pain cell line - Google Patents

Pain cell line

Info

Publication number: ZA964880B
Authority: ZA; South Africa
Prior art keywords: cell line; pain; pain cell; line; cell
Prior art date: 1995-06-07

Application number

ZA964880A

Other languages

English (en)

Inventor

Joel Saydoff

Shou Wong

Original Assignee

Cytotherapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1996-06-07

Publication date

1997-01-07

1996-06-07 Application filed by Cytotherapeutics Inc filed Critical Cytotherapeutics Inc

1997-01-07 Publication of ZA964880B publication Critical patent/ZA964880B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Toxicology (AREA)
Plant Pathology (AREA)
Dermatology (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Cell Biology (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ZA964880A 1995-06-07 1996-06-07 Pain cell line ZA964880B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US48191795A	1995-06-07	1995-06-07

Publications (1)

Publication Number	Publication Date
ZA964880B true ZA964880B (en)	1997-01-07

Family

ID=23913905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA964880A ZA964880B (en)	1995-06-07	1996-06-07	Pain cell line

Country Status (20)

Country	Link
EP (1)	EP0833935A1 (ja)
JP (1)	JPH11507530A (ja)
KR (1)	KR19990022414A (ja)
CN (1)	CN1192246A (ja)
AR (1)	AR004494A1 (ja)
AU (1)	AU6263696A (ja)
BR (1)	BR9608746A (ja)
CA (1)	CA2223246A1 (ja)
CZ (1)	CZ392497A3 (ja)
EE (1)	EE9700326A (ja)
HU (1)	HUP9901191A2 (ja)
IL (1)	IL122415A0 (ja)
IN (1)	IN181898B (ja)
IS (1)	IS4628A (ja)
NO (1)	NO975545L (ja)
PL (1)	PL323867A1 (ja)
SK (1)	SK167997A3 (ja)
TR (1)	TR199701520T1 (ja)
WO (1)	WO1996040959A1 (ja)
ZA (1)	ZA964880B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU751811B2 (en) *	1997-11-28	2002-08-29	Medical Research Council	Vectors
AU6151899A (en) *	1998-09-23	2000-04-10	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Methods of treating chronic pain
US6372489B1 (en)	1998-10-27	2002-04-16	Anticancer, Inc.	Method and model for hair pigmentation
EP1127121B1 (en) *	1998-10-27	2005-12-14	Anticancer, Inc.	Construction d'une retrovirus exprimant le locus mel de streptomyces, et son expression dans des cellules mammiferes
US6903244B1 (en)	1999-02-26	2005-06-07	University Of Utah Research Foundation	Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en)	2002-11-29	2002-12-12	The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland	Therapeutic and diagnostic agents
JP2007516984A (ja)	2003-12-24	2007-06-28	ザウォルターアンドエリザホールインスティテュートオブメディカルリサーチ	治療用物質およびそのための用途
JP4980211B2 (ja)	2004-05-12	2012-07-18	ウォルターアンドエリザホールインスティテュートオブメディカルリサーチ	細胞単離方法
CA2613480C (en)	2005-06-24	2015-10-20	The Walter And Eliza Hall Institute Of Medical Research	Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same
US9717775B2 (en)	2006-07-18	2017-08-01	University Of Utah Research Foundation	Methods for treating pain and screening analgesic compounds
US8889173B2 (en) *	2008-04-18	2014-11-18	Warsaw Orthopedic, Inc.	Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
JP6681826B2 (ja)	2013-05-31	2020-04-15	ザユニバーシティオブユタリサーチファウンデイション	コノトキシンペプチド、医薬組成物およびそれらの使用
AU2016345063B2 (en)	2015-10-27	2021-08-05	The Council Of The Queensland Institute Of Medical Research	A method of treatment and agents useful for same
CN107964047B (zh) *	2017-12-18	2018-11-02	哈尔滨工业大学	基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用
CN112891337A (zh) *	2021-03-26	2021-06-04	河北医科大学	高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995005452A2 (en) *	1993-08-12	1995-02-23	Cytotherapeutics, Inc.	Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules

1996
- 1996-06-05 IN IN1039CA1996 patent/IN181898B/en unknown
- 1996-06-06 AR ARP960102993A patent/AR004494A1/es unknown
- 1996-06-07 WO PCT/US1996/009629 patent/WO1996040959A1/en not_active Application Discontinuation
- 1996-06-07 PL PL96323867A patent/PL323867A1/xx unknown
- 1996-06-07 SK SK1679-97A patent/SK167997A3/sk unknown
- 1996-06-07 HU HU9901191A patent/HUP9901191A2/hu unknown
- 1996-06-07 TR TR97/01520T patent/TR199701520T1/xx unknown
- 1996-06-07 BR BR9608746A patent/BR9608746A/pt unknown
- 1996-06-07 CZ CZ973924A patent/CZ392497A3/cs unknown
- 1996-06-07 EE EE9700326A patent/EE9700326A/xx unknown
- 1996-06-07 KR KR1019970708894A patent/KR19990022414A/ko not_active Application Discontinuation
- 1996-06-07 ZA ZA964880A patent/ZA964880B/xx unknown
- 1996-06-07 EP EP96921403A patent/EP0833935A1/en not_active Withdrawn
- 1996-06-07 IL IL12241596A patent/IL122415A0/xx unknown
- 1996-06-07 CA CA002223246A patent/CA2223246A1/en not_active Abandoned
- 1996-06-07 JP JP9501908A patent/JPH11507530A/ja active Pending
- 1996-06-07 AU AU62636/96A patent/AU6263696A/en not_active Abandoned
- 1996-06-07 CN CN96195750A patent/CN1192246A/zh active Pending
1997
- 1997-12-02 NO NO975545A patent/NO975545L/no unknown
- 1997-12-04 IS IS4628A patent/IS4628A/is unknown

Also Published As

Publication number	Publication date
KR19990022414A (ko)	1999-03-25
NO975545D0 (no)	1997-12-02
CZ392497A3 (cs)	1998-12-16
WO1996040959A1 (en)	1996-12-19
NO975545L (no)	1998-02-04
IN181898B (ja)	1998-10-24
JPH11507530A (ja)	1999-07-06
SK167997A3 (en)	1998-05-06
EP0833935A1 (en)	1998-04-08
IS4628A (is)	1997-12-04
BR9608746A (pt)	1999-05-11
PL323867A1 (en)	1998-04-27
AU6263696A (en)	1996-12-30
TR199701520T1 (xx)	1998-04-21
EE9700326A (et)	1998-06-15
HUP9901191A2 (hu)	1999-08-30
IL122415A0 (en)	1998-06-15
CN1192246A (zh)	1998-09-02
AR004494A1 (es)	1998-12-16
CA2223246A1 (en)	1996-12-19

Publication	Publication Date	Title
IL125126A (en)	2003-01-12	Electroconversion cell
EP0745843A3 (en)	1997-03-19	Electrochemical immunosensor
GB2299202B (en)	1998-08-05	Battery
IL118756A0 (en)	1996-10-16	Ferroelectric cell
GB2302757B (en)	1998-02-11	Electrochemical cell
GB9507012D0 (en)	1995-05-31	Improved electrode
TW345318U (en)	1998-11-11	Battery connector
ZA964880B (en)	1997-01-07	Pain cell line
GB9512529D0 (en)	1995-08-23	Cell treatment
EP0810677A4 (en)	1998-04-01	LOW THICKNESS BATTERY
EP0854941A4 (en)	1998-12-09	ELECTROCHEMICAL SYSTEM
GB9510555D0 (en)	1995-07-19	Human cell lines
GB9425050D0 (en)	1995-02-08	Cell line
CA76159S (en)	1995-04-13	Battery
GB9422523D0 (en)	1995-01-04	Human cell lines
GB9507956D0 (en)	1995-06-07	Reference electrode
GB9522881D0 (en)	1996-01-10	Kinetomatic battery
GB9526094D0 (en)	1996-02-21	Battery
EP0821767A4 (en)	1998-07-01	RETENTION ELEMENT
GB9508129D0 (en)	1995-06-07	Cell modification
GB2306973B (en)	1997-10-15	Electrode structure
GB9508469D0 (en)	1995-06-14	Cell specific expression
GB9509810D0 (en)	1995-07-05	Cell specific expression
GB9511502D0 (en)	1995-08-02	Electrochemical methods
GB9709409D0 (en)	1997-07-02	Human cell lines